Meg J Jardine Selected Research

Phosphates (Orthophosphate)

11/2020	A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD).
12/2019	Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meg J Jardine Research Topics

Disease

37	Type 2 Diabetes Mellitus (MODY) 04/2024 - 11/2012
28	Chronic Renal Insufficiency 04/2024 - 09/2009
19	Kidney Diseases (Kidney Disease) 03/2024 - 06/2012
17	Renal Insufficiency (Renal Failure) 04/2024 - 06/2013
15	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 06/2012
15	Albuminuria 01/2023 - 11/2012
13	Heart Failure 04/2024 - 01/2019
12	Stroke (Strokes) 04/2024 - 02/2013
8	Myocardial Infarction 04/2024 - 02/2013
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2014
6	Infections 01/2024 - 01/2017
6	Hemorrhage 12/2023 - 02/2013
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 12/2019
5	Thrombosis (Thrombus) 05/2016 - 06/2012
3	Atrial Fibrillation 12/2023 - 01/2021
3	Hyperkalemia 12/2023 - 01/2019
3	Proteinuria 01/2022 - 01/2017
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 01/2017
3	Body Weight (Weight, Body) 01/2021 - 01/2019
2	Ischemic Stroke 12/2023 - 07/2023
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 11/2019
2	Hypertension (High Blood Pressure) 01/2021 - 09/2010
2	Malnutrition (Nutritional Deficiencies) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 01/2019
2	Diabetes Mellitus 01/2020 - 01/2019
1	Chronic Disease (Chronic Diseases) 04/2024
1	Metabolic Diseases (Metabolic Disease) 04/2024
1	Calciphylaxis 04/2024
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2024
1	Transient Ischemic Attack 07/2023
1	Soft Tissue Infections 01/2023
1	Mycoses (Diseases, Fungus) 01/2023
1	COVID-19 11/2022
1	Severe Acute Respiratory Syndrome 11/2022
1	Osteoporosis 01/2022
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2022
1	Polyneuropathies (Polyneuropathy) 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Nervous System Diseases (Neurological Disorders) 12/2021
1	Heart Diseases (Heart Disease) 12/2021
1	Hyperphosphatemia 11/2020
1	Vascular Calcification 11/2020
1	Foot Diseases 10/2020
1	Restless Legs Syndrome (Restless Legs) 01/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Hypokalemia 01/2020
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 12/2019

Drug/Important Bio-Agent (IBA)

31	CanagliflozinIBA 01/2023 - 12/2017
19	CreatinineIBA 11/2023 - 11/2012
17	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 01/2019
14	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 10/2018
11	SodiumIBA 04/2024 - 01/2019
9	AlbuminsIBA 01/2023 - 12/2017
8	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2019
5	SymportersIBA 04/2024 - 01/2019
4	AnticoagulantsIBA 12/2023 - 11/2013
4	Warfarin (Coumadin)FDA LinkGeneric 12/2023 - 11/2013
3	omega-Chloroacetophenone (Mace)IBA 04/2024 - 01/2021
3	Angiotensin Receptor AntagonistsIBA 12/2023 - 01/2020
3	Methylprednisolone FDA LinkGeneric 01/2022 - 01/2017
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 02/2013
3	PotassiumIBA 12/2021 - 01/2019
3	HomocysteineIBA 05/2016 - 06/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023 - 01/2020
2	DiureticsIBA 01/2021 - 01/2021
2	SteroidsIBA 01/2021 - 01/2017
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021 - 11/2020
2	Phosphates (Orthophosphate)IBA 11/2020 - 12/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017 - 06/2013
1	Fenofibrate (CiL)FDA LinkGeneric 03/2024
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2023
1	Cystatin CIBA 11/2023
1	RivaroxabanIBA 07/2023
1	Oxygen (Dioxygen)IBA 11/2022
1	Telmisartan (Micardis)FDA Link 11/2022
1	GlucocorticoidsIBA 01/2022
1	MineralsIBA 01/2022
1	MagnesiumIBA 07/2021
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	HematinicsIBA 11/2020
1	Fibroblast Growth Factor-23IBA 11/2020
1	Serum AlbuminIBA 01/2020
1	Mineralocorticoid Receptor AntagonistsIBA 01/2020
1	dapagliflozinIBA 01/2020
1	Parathyroid Hormone (Parathormone)IBA 12/2019
1	CalciumIBA 12/2019

Therapy/Procedure

17	Therapeutics 04/2024 - 09/2009
5	Renal Dialysis (Hemodialysis) 01/2021 - 01/2013
4	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2024 - 06/2012
3	Hemodiafiltration 01/2021 - 01/2013
3	Transplantation 01/2021 - 01/2019
2	Glycemic Control 01/2023 - 10/2017
2	Drug Tapering 01/2022 - 01/2019
2	Kidney Transplantation 01/2021 - 01/2009
2	Surgical Amputation (Amputations) 10/2020 - 05/2016
2	Catheters 04/2016 - 11/2013
1	Antibiotic Prophylaxis 01/2022
1	Diet Therapy (Therapy, Diet) 01/2020
1	Plant-Based Diet 01/2020